NLys(2/3) variants 3

General Information


DRACP ID  DRACP05698

Peptide Name   NLys(2/3) variants 3

Sequence  ZZZZZZZZXXXXX

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  5(6)-Carboxyfluorescein

C-terminal Modification  Amidation

Other Modification  Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; X=NLeu from isobutylamine

Chiral  L



Physicochemical Information


Formula  H-24O-12

Absent amino acids  ACDEFGHIKLMNPQRSTVWY

Common amino acids  X

Mass  54802

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  0

Net charge  0

Boman Index  0

Hydrophobicity  0

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22828784

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2754

DRACP is developed by Dr.Zheng's team.